Abstract
Profound changes in maternal physiology occur during pregnancy to accommodate the growing fetus. Understanding these changes is fundamental to proper management of the obstetric patient and identification of pathologic changes. This chapter provides an overview of the obstetric patient and serves to familiarize the rheumatologist with pregnancy. First, we address normal fetal development followed by the various maternal physiologic changes that occur in major organ systems. Next we address antenatal care and fetal surveillance. Finally, we discuss common complications of pregnancy, some of which may mimic rheumatologic conditions or occur in greater frequency in the woman with underlying rheumatic disease. This chapter lays the foundation required to understand the nuances of pregnancy management in each specific rheumatologic disease.
Keywords
- Down Syndrome
- Fetal Growth Restriction
- Hypertensive Disorder
- Gestational Hypertension
- Severe Preeclampsia
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Monga M. Maternal cardiovascular, respiratory, and renal adaptation to pregnancy. In: Creasy RK, Resnik R, Iams JD, Lockwood CJ, Moore TR, editors. Maternal-fetal medicine: principles and practice. 6th ed. Philadelphia: Saunders; 2009. p. 102.
Ueland K, Metcalfe J. Circulatory changes in pregnancy. Clin Obstet Gynecol. 1975;18:41–50.
Laird-Meeter K, Van de Ley G, Bom TH, et al. Cardiocirculatory adjustments during pregnancy—an echocardiographic study. Clin Cardiol. 1979;2:328–32.
James C, Banner T, Caton D. Cardiac output in women undergoing cesarean section with epidural or general anesthesia. Am J Obstet Gynecol. 1989;160:1178.
Crapo R. Normal cardiopulmonary physiology during pregnancy. Clin Obstet Gynecol. 1996;39:3–16.
Prowse CM, Gaensler EA. Respiratory and acid–base changes during pregnancy. Anesthesiology. 1965;26:381–92.
Elkus R, Popovich J. Respiratory physiology in pregnancy. Clin Chest Med. 1992;13:555–65.
McAuliffe F, Kametas N, Costello J, et al. Respiratory function in singleton and twin pregnancy. BJOG. 2002;109:765–9.
Lucius H, Gahlenbeck H, Kleine H-O, et al. Respiratory functions, buffer system, and electrolyte concentrations of blood during human pregnancy. Respir Physiol. 1970;9:311–7.
Dunlop W. Serial changes in renal hemodynamics during normal human pregnancy. BJOG. 1981;88:1.
Conrad KP, Lindheimer MD. Renal and cardiovascular alterations. In: Lindheimer MD, Roberts JM, Cunningham FG, editors. Chesley’s hypertensive disorders in pregnancy. 2nd ed. Stamford: Appleton and Lange; 1999. p. 263–326.
Davison J, Hytten F. The effect of pregnancy on the renal handling of glucose. Br J Obstet Gynaecol. 1975;82:374.
Fried A, Woodring JH, Thompson TJ. Hydronephrosis of pregnancy. J Ultrasound Med. 1983;2:255.
Girling JC, Dow E, Smith JH. Liver function tests in pre-eclampsia: importance of comparison with a reference range derived for normal pregnancy. BJOG. 1997;104:246–50.
Ensom M, Liu P, Stephenson M. Effect of pregnancy on bone mineral density in healthy women. Obstet Gynecol Surv. 2002;57:99.
Karlsson MK, Ahlborg HG, Karlsson C. Maternity and bone mineral density. Acta Orthop. 2005;76(1):2–13.
Keriakos R, Bhatta SR, Morris F, Mason S, Buckley S. Pelvic girdle pain during pregnancy and puerperium. J Obstet Gynaecol. 2011;31(7):572–80.
American College of Obstetricians and Gynecologists. ACOG practice bulletin 77: screening for fetal chromosomal abnormalities. Obstet Gynecol. 2007;109:217–27.
Bianchi DW, Platt LD, Goldberg JD, Abuhamad AZ, Sehnert AJ, Rava RP, et al. Genome-wide fetal aneuploidy detection by maternal plasma DNA sequencing. Obstet Gynecol. 2012;119:890–901.
Alfirevic Z, Stampalija T, Gyte GML. Fetal and umbilical Doppler ultrasound in high-risk pregnancies. Cochrane Database Syst Rev. 2010;(1), Art. No: CD007529. doi:10.1002/14651858.CD007529.pub2
Norwitz ER, Schust DJ, Fisher SJ. Implantation and the survival of early pregnancy. N Engl J Med. 2001;345:1400–8.
Simpson JL, Mills JL, Holmes LB, et al. Low fetal loss rates after ultrasound-proved viability in early pregnancy. JAMA. 1987;258:2555–7.
MacDorman MFL, Kirmeyer SE, Wilson EC. Fetal and perinatal mortality, United States, 2006. Natl Vital Stat Rep. 2012;60(8).
The Stillbirth Collaborative Research Network Writing Group. Causes of death among stillbirths. JAMA. 2011;306:2459–68.
Alexander JM, Bloom SL, McIntire DD, Leveno KJ. Severe preeclampsia and the very low birth weight infant: is induction of labor harmful? Obstet Gynecol. 1999;93(4):485.
Nassar AH, Adra AM, Chakhtoura N, Gómez-Marín O, Beydoun S. Severe preeclampsia remote from term: labor induction or elective cesarean delivery? Am J Obstet Gynecol. 1998;179(5):1210.
Haram K, Svendsen E, Abildgaard U. The HELLP syndrome: clinical issues and management. A review. BMC Pregnancy Childbirth. 2009;9:8.
Williamson C, Mackillop L. Diseases of the liver, biliary system, and pancreas. In: Creasy RK, Resnik R, Iams JD, Lockwood CJ, Moore TR, editors. Maternal-fetal medicine: principles and practice. 6th ed. Philadelphia: Saunders; 2009. p. 1059–77.
Woudstra DM, Chandra S, Hofmeyr GJ, Dowswell T. Corticosteroids for HELLP (hemolysis, elevated liver enzymes, low platelets) syndrome in pregnancy. Cochrane Database Syst Rev 2010;(9):CD008148.
Duley L, Gulmezoglu AM, Henderson-Smart DJ. Magnesium sulphate and other anticonvulsants for women with pre-eclampsia. Cochrane Database Syst Rev. 2010;11:CD000025.
Jewell D, Young G. Interventions for nausea and vomiting in early pregnancy (Cochrane review). In: The Cochrane library, issue 4. Chichester: Wiley; 2003.
Saleh M, Abdo K. Intrahepatic cholestasis of pregnancy: review of the literature and evaluation of current evidence. J Womens Health. 2007;16(6):833–41.
Williamson C, Gorelik J, Eaton BM, et al. The bile acid taurocholate impairs rat cardiomyocyte function: a proposed mechanism for intra-uterine fetal death in obstetric cholestasis. Clin Sci (Lond). 2001;100(4):363–9.
Gorelik J, Harding SE, Shevchuk AI, et al. Taurocholate induces changes in rat cardiomyocyte contraction and calcium dynamics. Clin Sci (Lond). 2002;103(2):191–200.
Williamson C, Miragoli M, Sheikh Abdul Kadir S, Abu-Hayyeh S, Papacleovoulou G, Geenes V, Gorelik J. Bile acid signaling in fetal tissues: implications for intrahepatic cholestasis of pregnancy. Dig Dis. 2011;29(1):58–61.
Kenyon AP, Percy CN, Girling J, et al. Obstetric cholestasis, outcome with active management: a series of 70 cases. BJOG. 2002;109(3):282–8.
Gorelik J, Shevchuk A, de Swiet M, et al. Comparison of the arrhythmogenic effects of tauro- and glycoconjugates of cholic acid in an in vitro study of rat cardiomyocytes. BJOG. 2004;111(8):867–70.
Williamson C, Hems L, Goulis D, et al. Clinical outcome in a series of cases of obstetric cholestasis identified via a patient support group. BJOG. 2004;111(7):676–81.
Sibai BM. Imitators of severe pre-eclampsia. Semin Perinatol. 2009;33:196–205.
Vigil-DeGracia P, Lavergue JA. Acute fatty liver of pregnancy. Int J Gynecol Obstet. 2001;72:193–5.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this chapter
Cite this chapter
Branch, D.W., Wong, L.F. (2014). Normal Pregnancy, Pregnancy Complications, and Obstetric Management. In: Sammaritano, L., Bermas, B. (eds) Contraception and Pregnancy in Patients with Rheumatic Disease. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-0673-4_2
Download citation
DOI: https://doi.org/10.1007/978-1-4939-0673-4_2
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4939-0672-7
Online ISBN: 978-1-4939-0673-4
eBook Packages: MedicineMedicine (R0)